Product Description: Ginisortamab (UCB6114) is a fully human IgG4P antiGremlin-1 monoclonal antibody. Ginisortamab has the potential for the research of gastrointestinal (GI) tumors[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Debashis Sarker, et al. A multi-modular phase I/II study of UCB6114, a first-in-class, fully human IgG4P anti-Gremlin-1 monoclonal antibody, as monotherapy and in combination with mFOLFOX6 or trifluridine/tipiracil, for patients with advanced gastrointestinal (GI) tumors. Meeting Abstract, 2022 ASCO Gastrointestinal Cancers Symposium.
CAS Number: 2390147-17-6
Molecular Weight: N/A
Compound Purity: 99.05
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Others